Mohammad Imran

ORCID: 0000-0002-3461-0152
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advancements in Transdermal Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • RNA Interference and Gene Delivery
  • Skin Protection and Aging
  • Curcumin's Biomedical Applications
  • Advanced Drug Delivery Systems
  • Bacterial biofilms and quorum sensing
  • Toxin Mechanisms and Immunotoxins
  • Dermatology and Skin Diseases
  • Lipid metabolism and disorders
  • Electrospun Nanofibers in Biomedical Applications
  • Vitamin C and Antioxidants Research
  • Essential Oils and Antimicrobial Activity
  • Graphene and Nanomaterials Applications
  • Immunotherapy and Immune Responses
  • 3D Printing in Biomedical Research
  • Nanoplatforms for cancer theranostics
  • Antibiotic Resistance in Bacteria
  • melanin and skin pigmentation
  • Lipid Membrane Structure and Behavior
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Vitamin D Research Studies
  • Analytical Chemistry and Chromatography
  • Antimicrobial Peptides and Activities
  • Cannabis and Cannabinoid Research

The University of Queensland
2022-2025

Southern Illinois University Carbondale
2024

Robert Morris University
2024

Jamia Hamdard
2019-2023

Institute of Nano Science and Technology
2021-2022

Indian Institute of Science Education and Research Mohali
2021-2022

Northern Border University
2019-2022

Cloud Computing Center
2021

University of the Punjab
2020

Integral University
2019

The metabolic syndrome (MetS), first introduced by Haller in 1975, was sometimes also known as insulin resistance syndrome, X, and plurimetabolic syndrome. In 1989, it rechristened Kaplan the “Deadly Quartet” based on a consolidation of central obesity, impaired glucose tolerance, dyslipidemia, systemic hypertension. MetS is positively associated with pro-inflammatory pro-thrombotic state, attributed to increased inflammatory marker activity. Moreover, frequently atherosclerotic...

10.3390/diabetology4020015 article EN cc-by Diabetology 2023-04-12

Recent advances in topical and transdermal drug delivery systems have enabled targeted of therapeutics to the site action by enhancing permeation across stratum corneum increased bioavailability. Despite various technological advancements, some dermatoses still limited treatment options due potential adverse effects challenges formulation development. To address limitations posed conventional dermatotherapy, nano-based technologies been developed demonstrated a significant improvement...

10.3389/fddev.2022.957732 article EN cc-by Frontiers in Drug Delivery 2022-09-05

Osteoarthritis (OA) is a well-known degenerative joint disease recognized by the deterioration of cartilage in joints, leading to pain and reduced mobility. Traditional treatments for OA include management, physical therapy, severe cases, replacement surgery. In recent years, there has been growing interest exploring potential phytoconstituents nanomedicines combined treating OA. Furthermore, with increasing amount study this field, now opportune time widespread use plant-derived medications...

10.1016/j.eurpolymj.2024.113243 article EN cc-by European Polymer Journal 2024-07-01
Coming Soon ...